We offer specialized Progesterone 100 mg Base MBK™ Suppositories for treating endometriosis in women. Our formulation is designed to deliver a controlled and sustained release of Progesterone in the region of the uterus, providing a therapeutic benefit to the target area. Furthermore, our suppository formulation has been found to be superior in transvaginal bioavailability, demonstrated to have a much higher residence time in the uterus, when compared to other bioidentical delivery systems. This allows for more effective treatment, decreased systemic absorption, and a reduction in the risk of systemic side effects. As a doctor, if you have any questions about our MBK™ Progesterone 100 mg Base Suppositories or their use in treating endometriosis, please reach out to us for further information.
We offer specialized Progesterone 100 mg Base MBK™ Suppositories for treating endometriosis in women. Our formulation is designed to deliver a controlled and sustained release of Progesterone in the region of the uterus, providing a therapeutic benefit to the target area. Furthermore, our suppository formulation has been found to be superior in transvaginal bioavailability, demonstrated to have a much higher residence time in the uterus, when compared to other bioidentical delivery systems. This allows for more effective treatment, decreased systemic absorption, and a reduction in the risk of systemic side effects. As a doctor, if you have any questions about our MBK™ Progesterone 100 mg Base Suppositories or their use in treating endometriosis, please reach out to us for further information.